目的:评价拮抗剂方案中不同卵巢反应患者雌激素预处理的效果。方法:检索数据库(PubMed、Web of Science、中国知网、万方数据库)中关于雌激素预处理在拮抗剂方案中作用的研究进行meta分析。结果:纳入7篇随机临床对照研究、2篇回顾性研...目的:评价拮抗剂方案中不同卵巢反应患者雌激素预处理的效果。方法:检索数据库(PubMed、Web of Science、中国知网、万方数据库)中关于雌激素预处理在拮抗剂方案中作用的研究进行meta分析。结果:纳入7篇随机临床对照研究、2篇回顾性研究。为了进一步探索异质性的来源,采用亚组分析,主要根据研究实际纳入人群的卵巢反应性进行亚组分析,分为低反应、非低反应、混合反应组;在促性腺激素(gonadotropin hormone,Gn)天数研究时根据用药方式分为洗脱组(停用雌激素预处理5~6 d后开始促排卵)及非洗脱组(雌激素预处理用至促排卵启动前一日)进行分析。在非洗脱组中[WMD=1.07,95%CI(0.83,1.31),I2=66%]预处理后Gn天数显著增加。在洗脱组中[WMD=-0.12,95%CI(-0.45,0.21),I2=0%]Gn天数无明显变化。预处理在低反应亚组中均不影响获卵数[WMD=0.46,95%CI(-0.23,1.16),I2=81%]、临床妊娠率[RR=0.77,95%CI(0.55,1.06),I2=73%]及周期取消率[RR=0.80,95%CI(0.40,1.61),I2=83%];在非低反应组中均不影响获卵数[WMD=0.21,95%CI(-0.69,1.11),I2=22%]、临床妊娠率[RR=0.94,95%CI(0.77,1.14),I2=41%]、活产率[RR=0.82,95%CI(0.62,1.08),I2=0%]及周期取消率[RR=0.89,95%CI(0.54,1.47),I2=2%]。结论:拮抗剂方案中雌激素预处理(非洗脱)会增加Gn天数,不改善非低反应及低反应者体外受精结局。雌激素预处理的应用还需谨慎对待。展开更多
Objective:To evaluate the effect of estrogen pre-treatment in patients with different ovarian response in antagonist protocol.Methods:Randomized controlled trials(RCTs)and retrospective studies about the effect of est...Objective:To evaluate the effect of estrogen pre-treatment in patients with different ovarian response in antagonist protocol.Methods:Randomized controlled trials(RCTs)and retrospective studies about the effect of estrogen pre-treatment in antagonist prorocol were searched in PubMed,Web of Science,China National Knowledge Infrastructure,Wanfang Database.R software was used for meta-analysis.Results:Seven RCTs and two retrospective studies were included.In order to explore the source of heterogeneity,subgroup analysis was used,which was mainly conducted according to the ovarian response of the included population,which were divided into low responders,non-low responders and mixed responders.In the study about gonadotropin hormone(Gn)days,patients were divided into wash-out subgroup and non-wash-out subgroup according to drug use-pattern.Meta-results showed that the number of Gn days increased significantly in the non-wash-out subgroup(WMD=1.07,95%CI[0.83;1.31],I2=66%).The number of Gn days in the wash-out subgroup were not affected(WMD=-0.12,95%CI[-0.45;0.21],I2=0%).In the low-response subgroup,the number of oocytes retrieved(WMD=0.46,95%CI[-0.23;1.16],I2=81%),the fresh cycle clinical pregnancy rate(RR=0.77,95%CI[0.55;1.06],I2=73%)and the cycle cancellation rate(RR=0.80,95%CI[0.40;1.61],I2=83%)were not significantly changed with estrogen pre-treatment.In the non-low-response subgroup,the number of oocytes obtained(WMD=0.21,95%CI[-0.69;1.11],I2=2%),fresh cycle clinical pregnancy rate(RR=0.94,95%CI[0.77;1.14],I2=41%),live birth rate(RR=0.82,95%CI[0.62;1.08],I2=0%)and cycle cancellation rate(RR=0.89,95%CI[0.54;1.47],I2=2%)were not significantly changed with estrogen pre-treatment.Conclusions:Estrogen pre-treatment(with non-wash-out period)in antagonist protocol increases Gn days,dose not improve IVF outcomes in non-low responders and low responders.展开更多
A novel organic nonlinear material 4-dimethylamino-N-methyl-4-stilbazolium tosylate which was designed to have a donor/π-conjugated/acceptor structure was synthesized via an effective method.By this method,we have ra...A novel organic nonlinear material 4-dimethylamino-N-methyl-4-stilbazolium tosylate which was designed to have a donor/π-conjugated/acceptor structure was synthesized via an effective method.By this method,we have raised yields of every step.Red product with metal luster surface is obtained after repeated purification.The purification process was effective and less-product-lost.Nuclear magnetic resonance study and FTIR were performed to identify the molecular.展开更多
文摘目的:评价拮抗剂方案中不同卵巢反应患者雌激素预处理的效果。方法:检索数据库(PubMed、Web of Science、中国知网、万方数据库)中关于雌激素预处理在拮抗剂方案中作用的研究进行meta分析。结果:纳入7篇随机临床对照研究、2篇回顾性研究。为了进一步探索异质性的来源,采用亚组分析,主要根据研究实际纳入人群的卵巢反应性进行亚组分析,分为低反应、非低反应、混合反应组;在促性腺激素(gonadotropin hormone,Gn)天数研究时根据用药方式分为洗脱组(停用雌激素预处理5~6 d后开始促排卵)及非洗脱组(雌激素预处理用至促排卵启动前一日)进行分析。在非洗脱组中[WMD=1.07,95%CI(0.83,1.31),I2=66%]预处理后Gn天数显著增加。在洗脱组中[WMD=-0.12,95%CI(-0.45,0.21),I2=0%]Gn天数无明显变化。预处理在低反应亚组中均不影响获卵数[WMD=0.46,95%CI(-0.23,1.16),I2=81%]、临床妊娠率[RR=0.77,95%CI(0.55,1.06),I2=73%]及周期取消率[RR=0.80,95%CI(0.40,1.61),I2=83%];在非低反应组中均不影响获卵数[WMD=0.21,95%CI(-0.69,1.11),I2=22%]、临床妊娠率[RR=0.94,95%CI(0.77,1.14),I2=41%]、活产率[RR=0.82,95%CI(0.62,1.08),I2=0%]及周期取消率[RR=0.89,95%CI(0.54,1.47),I2=2%]。结论:拮抗剂方案中雌激素预处理(非洗脱)会增加Gn天数,不改善非低反应及低反应者体外受精结局。雌激素预处理的应用还需谨慎对待。
基金Hainan Clinical Medical CenterMajor Science and Technology Project of Hainan Province(No.ZDKJ2021037)+3 种基金National Natural Science Foundation of China(No.81960283,82072880)Funded by the Innovation Center of Academician Team of Hainan ProvinceKey R&D Project of Hainan Province(No.ZDYF2022SHFZ311)Hainan Science and Technology Program(Clinical Medical Research Center:LCYX202203,LCYX202102)。
文摘Objective:To evaluate the effect of estrogen pre-treatment in patients with different ovarian response in antagonist protocol.Methods:Randomized controlled trials(RCTs)and retrospective studies about the effect of estrogen pre-treatment in antagonist prorocol were searched in PubMed,Web of Science,China National Knowledge Infrastructure,Wanfang Database.R software was used for meta-analysis.Results:Seven RCTs and two retrospective studies were included.In order to explore the source of heterogeneity,subgroup analysis was used,which was mainly conducted according to the ovarian response of the included population,which were divided into low responders,non-low responders and mixed responders.In the study about gonadotropin hormone(Gn)days,patients were divided into wash-out subgroup and non-wash-out subgroup according to drug use-pattern.Meta-results showed that the number of Gn days increased significantly in the non-wash-out subgroup(WMD=1.07,95%CI[0.83;1.31],I2=66%).The number of Gn days in the wash-out subgroup were not affected(WMD=-0.12,95%CI[-0.45;0.21],I2=0%).In the low-response subgroup,the number of oocytes retrieved(WMD=0.46,95%CI[-0.23;1.16],I2=81%),the fresh cycle clinical pregnancy rate(RR=0.77,95%CI[0.55;1.06],I2=73%)and the cycle cancellation rate(RR=0.80,95%CI[0.40;1.61],I2=83%)were not significantly changed with estrogen pre-treatment.In the non-low-response subgroup,the number of oocytes obtained(WMD=0.21,95%CI[-0.69;1.11],I2=2%),fresh cycle clinical pregnancy rate(RR=0.94,95%CI[0.77;1.14],I2=41%),live birth rate(RR=0.82,95%CI[0.62;1.08],I2=0%)and cycle cancellation rate(RR=0.89,95%CI[0.54;1.47],I2=2%)were not significantly changed with estrogen pre-treatment.Conclusions:Estrogen pre-treatment(with non-wash-out period)in antagonist protocol increases Gn days,dose not improve IVF outcomes in non-low responders and low responders.
文摘A novel organic nonlinear material 4-dimethylamino-N-methyl-4-stilbazolium tosylate which was designed to have a donor/π-conjugated/acceptor structure was synthesized via an effective method.By this method,we have raised yields of every step.Red product with metal luster surface is obtained after repeated purification.The purification process was effective and less-product-lost.Nuclear magnetic resonance study and FTIR were performed to identify the molecular.